<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Initial evaluation of an infant with atypical genitalia for disorders of sex development: Overview</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Initial evaluation of an infant with atypical genitalia for disorders of sex development: Overview</h1>
<div class="graphic"><div class="figure"><div class="ttl">Initial evaluation of an infant with atypical genitalia for disorders of sex development: Overview</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="16%"></colgroup><colgroup span="2" width="33%"></colgroup> <tbody> <tr> <td class="subtitle1_left" colspan="4">Clinical features</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Newborn infant with:</td> </tr> <tr> <td class="indent1" colspan="4">Largely male appearance of the external genitalia and any of the following: <ul class="decimal_heading"> <li>Bilaterally nonpalpable gonads</li> <li>Severe hypospadias</li> <li>Any degree of hypospadias accompanied by unilateral or bilateral cryptorchidism and/or micropenis</li> </ul> </td> </tr> <tr> <td class="indent1" colspan="4">Largely female appearance of the external genitalia and any of the following: <ul class="decimal_heading"> <li>Clitoromegaly</li> <li>Posterior labial fusion</li> <li>Gonads palpable in the labioscrotal folds or inguinal region</li> <li>Genital appearance discordant with sex chromosomes</li> </ul> </td> </tr> <tr> <td class="subtitle1_left" colspan="4">Family communication</td> </tr> <tr> <td class="indent1" colspan="4">Congratulate family on the new addition.</td> </tr> <tr> <td class="indent1" colspan="4">If the baby is healthy, reassure the family.</td> </tr> <tr> <td class="indent1" colspan="4">Avoid premature designation of gender, naming of the baby, and completion of the birth certificate; counsel that it will take days or weeks to conduct the initial evaluation.</td> </tr> <tr> <td class="subtitle1_left" colspan="4">Initial laboratory testing</td> </tr> <tr> <td class="indent1" colspan="4">Expedited determination of sex chromosomes (karyotype or other method).</td> </tr> <tr> <td class="indent1" colspan="4">Adrenal steroids – 17-OHP (essential; this test is part of newborn screening in the United States). Tests for uncommon causes of CAH (17-hydroxypregnenolone, cortisol, 11-deoxycortisol) are sometimes done at this point but may be deferred to minimize blood loss.</td> </tr> <tr> <td class="indent1" colspan="4">Gonadal function – FSH, LH, testosterone<sup>*</sup>, dihydrotestosterone, AMH.</td> </tr> <tr> <td class="indent1" colspan="4">Electrolytes (baseline; follow every 24 to 48 hours until CAH is confirmed or excluded).</td> </tr> <tr> <td class="indent1" colspan="4">Abdominal and pelvic ultrasound to assess for gonads, uterus, and vagina.</td> </tr> <tr> <td class="subtitle1_left" colspan="4">Interpretation and next steps</td> </tr> <tr> <td class="subtitle2_left" colspan="4" style="background-color: #E6F2F9;">XX karyotype</td> </tr> <tr> <td class="subtitle2_left indent1">17-OHP</td> <td class="subtitle2_left">AMH</td> <td class="subtitle2_left">Likely diagnosis</td> <td class="subtitle2_left">Comments</td> </tr> <tr> <td class="indent2">Very elevated</td> <td>Within female range</td> <td> <ul> <li>CAH due to 21-hydroxylase deficiency</li> </ul> </td> <td> <ul> <li>Risk for adrenal crisis; treat immediately</li> <li>Gonads are not palpable</li> </ul> </td> </tr> <tr> <td class="indent2">Elevated</td> <td>Within female range</td> <td> <ul> <li>CAH due to 21-hydroxylase deficiency</li> <li>Other form of XX CAH<sup>¶</sup></li> <li>Stress</li> </ul> </td> <td> <ul> <li>Risk for adrenal crisis</li> <li>Follow electrolytes</li> <li>Repeat 17-OHP if stress is present</li> <li>Interpret other adrenal steroids and/or ACTH stimulation test for definitive diagnosis</li> </ul> </td> </tr> <tr> <td class="indent2">Normal</td> <td>Within female range</td> <td> <ul> <li>Gestational hyperandrogenism</li> </ul> </td> <td> <ul> <li>Maternal virilization during pregnancy</li> </ul> </td> </tr> <tr> <td class="indent2">Normal</td> <td>Elevated above female range</td> <td> <ul> <li>Testicular or ovotesticular DSD</li> </ul> </td> <td> <ul> <li>Elevated testosterone and AMH (above female range) suggests that testicular tissue is present</li> <li>To determine cause, test for presence of <em>SRY</em>, sequence <em>NR5A1</em>, and consider next-generation sequencing</li> <li>May have palpable gonads</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="4" style="background-color: #E6F2F9;">XY karyotype</td> </tr> <tr> <td class="subtitle2_left indent1">Ultrasound</td> <td class="subtitle2_left">AMH</td> <td class="subtitle2_left">Likely diagnosis or category</td> <td class="subtitle2_left">Comments</td> </tr> <tr> <td class="indent2">No uterus</td> <td>Within male range</td> <td> <ul> <li>Defect in androgen synthesis or action</li> </ul> </td> <td> <ul> <li>Testosterone:dihydrotestosterone (when expressed in same units) &lt;10:1 (normal) <ul> <li>Elevated testosterone – Probable AIS</li> <li>Normal testosterone – Likely AIS, possible 17-beta-HSD or partial gonadal dysgenesis</li> <li>Low testosterone – 3-beta-HSD2 or other forms of XY CAH<sup>Δ</sup></li> </ul> </li> <li>Testosterone:dihydrotestosterone &gt;10:1 (elevated) <ul> <li>5-alpha-reductase deficiency</li> </ul> </li> <li>If LH is low, repeat after 2 weeks of age or consider hCG stimulation testing</li> </ul> </td> </tr> <tr> <td class="indent2">Uterus present or absent</td> <td>Below male range</td> <td> <ul> <li>Gonadal dysgenesis (global impairment of testicular function)</li> </ul> </td> <td> <ul> <li>Genetic testing to determine cause: <ul> <li><em>NR5A1</em> sequencing</li> <li>Other mutations<sup>◊</sup></li> </ul> </li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="4" style="background-color: #E6F2F9;">Y chromosome mosaicism/chimerism (eg, 45,X/46,XY)</td> </tr> <tr> <td class="subtitle2_left indent1" colspan="2">Gonads</td> <td class="subtitle2_left">Likely diagnosis or category</td> <td class="subtitle2_left">Comments</td> </tr> <tr> <td class="indent2" colspan="2">Many possibilities: <ul class="decimal_heading"> <li>Normal or dysgenetic testes</li> <li>Normal or dysgenetic ovaries</li> <li>Streak gonads</li> <li>Ovotestes</li> <li>Mixed gonadal dysgenesis<sup>§</sup></li> </ul> </td> <td> <ul> <li>Sex chromosome DSD</li> </ul> </td> <td> <ul> <li>Increased risk for gonadoblastoma if dysgenetic gonad is present</li> <li>If 45,X karyotype in some cells, evaluate with echocardiography and kidney ultrasound</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>17-beta-HSD: 17-beta-hydroxysteroid dehydrogenase deficiency; 
        17-OHP: 17-hydroxyprogesterone; 
        3-beta-HSD2: 3-beta-hydroxysteroid dehydrogenase type 2 deficiency; 
        ACTH: adrenocorticotropic hormone; 
        AIS: androgen insensitivity syndrome; 
        AMH: anti-müllerian hormone; 
        CAH: congenital adrenal hyperplasia; 
        DSD: disorder of sex development; 
        FSH: follicle-stimulating hormone; 
        hCG: human chorionic gonadotropin; 
        LH: luteinizing hormone.</p>
<p>* Testosterone tests should be performed no sooner than 48 hours of life. Samples taken during the first few days of life may not be a valid reflection of testicular function, because of transient suppression of gonadotropins after birth. LH should be measured concurrently to determine whether there is sufficient stimulus to Leydig cells to produce testosterone. The assay should be performed using gas or liquid chromatography/mass spectroscopy because interfering substances in neonates may give falsely elevated results on immunoassay.</p>
<p>¶ Forms of CAH that present with atypical genitalia in an XX infant include 21-hydroxylase deficiency (by far the most common), 11-beta-hydroxylase deficiency, 3-beta-HSD2, and P450 oxidoreductase deficiency.</p>
<p>Δ 3-beta-HSD2 is characterized by high 17-hydroxypregnenolone and high 17-hydroxypregnenolone:cortisol ratio.</p>
<p>◊ In addition to <em>NR5A1</em>, gene mutations that have been associated with gonadal dysgenesis include <em>SRY</em>, <em>WT1</em>, <em>NROB1</em> (gain-of-function); <em>MAP3K1</em>, <em>CBX2</em>, <em>DHH</em>, <em>DMRT1</em>, <em>FGF9</em>, <em>FOG</em>, <em>GATA4</em>, <em>SOX9</em>, and <em>ZFPM2</em>; and Y chromosome mosaicism.</p>
    
    § Mixed gonadal dysgenesis refers to asymmetric gonadal development with Y chromosome mosaicism. In most cases, the right gonad has testicular tissue and the left gonad is a streak gonad or an ovary.</div><div id="graphicVersion">Graphic 118482 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
